POT1 and B-cell chronic lymphocytic leukemia: Andrew et al. identified twelve (3.5%) POT1 somatic mutations in chronic lymphocytic leukemia (CLL), the majority affecting the two oligonucleotide/oligosaccharide-binding (OB) folds suggested to have an essential role in binding to the telomeric repeats and for protein function [10].